ScholarIQanswers from OpenAlex

Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae

PaperCitations, authors & open-access status

Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae have?

ScholarIQcitation count

Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae published?

ScholarIQyear

Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae has 2023 year in the ScholarIQ index.

What is the open-access status of Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae?

ScholarIQoa status

Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae has gold oa status in the ScholarIQ index.

What is the DOI of Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae?

ScholarIQdoi

The DOI for Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae is on the source record.

What is the PMID of Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae?

ScholarIQpmid

The PMID for Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae is on the source record.

What is the OpenAlex record for Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae?

ScholarIQopenalex

The OpenAlex for Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial